Dolphin Medical Services last traded at ₹6.31 (2026-10-13). Over the past month the stock moved +0.0%, three months the stock moved -12.0%, year the stock moved +189.4%. Its closing range over 52 weeks is ₹2.05 – ₹7.49, with the latest close 15.8% below the high.
Closing prices up to 2026-10-13.
Incorporated in 1984, Dolphin Medical Services Ltd is in the business of diagnostics and other allied services.[1]
Business Overview:[1] a) DMSL provides a range of tests covering Radiology and Imaging, Biochemistry, Pathology, and Microbiology, etc., to the people of the coastal region of Andhra Pradesh. b) Additionally, it has the eye care division called the Dolphin Nethralaya which is a comprehensive eye care and a laser and research centre. c) The company has also ventured into IT and Biotechnology and Herbal sectors
In the latest quarter (Jun 2026), Dolphin Medical Services reported sales of ₹0.21 crore (+23.5%) and net profit of ₹0.02 crore (-33.3%), compared with the same quarter last year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Jun 2026 | 0.21 | 0.03 | 14.29 | 0.02 | 0.01 |
| Mar 2026 | 0.19 | 0.02 | 10.53 | 0.01 | 0.01 |
| Dec 2025 | 0.21 | 0.03 | 14.29 | 0.02 | 0.01 |
| Sep 2025 | 0.18 | 0.02 | 11.11 | 0.01 | 0.01 |
| Jun 2025 | 0.17 | 0.03 | 17.65 | 0.03 | 0.02 |
| Mar 2025 | 0.14 | -0.05 | -35.71 | -0.07 | -0.05 |
| Dec 2024 | 0.24 | 0.01 | 4.17 | 0.01 | 0.01 |
| Sep 2024 | 0.25 | 0.02 | 8.00 | 0.02 | 0.01 |
| Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales growth | +38.9% | +20.0% | +0.0% | +21.4% | -28.0% | -12.5% | +35.7% | +23.5% |
| Operating profit growth | +100.0% | – | – | +200.0% | +0.0% | +200.0% | – | +0.0% |
| Net profit growth | +100.0% | – | – | +200.0% | -50.0% | +100.0% | – | -33.3% |
| EPS growth | +0.0% | – | – | +100.0% | +0.0% | +0.0% | – | -50.0% |
| OPM % | 8.0% | 4.2% | -35.7% | 17.7% | 11.1% | 14.3% | 10.5% | 14.3% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
In the latest year (Mar 2026), Dolphin Medical Services reported sales of ₹0.75 crore (-3.8%) and net profit of ₹0.04 crore, compared with the previous year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Mar 2026 | 0.75 | 0.12 | 16.00 | 0.04 | 0.03 |
| Mar 2025 | 0.78 | 0.00 | 0.00 | -0.03 | -0.02 |
| Mar 2024 | 0.68 | -0.08 | -11.76 | -0.10 | -0.07 |
| Mar 2023 | 0.61 | -0.08 | -13.11 | -0.12 | -0.08 |
| Mar 2022 | 0.52 | -0.14 | -26.92 | -0.19 | -0.13 |
| Mar 2021 | 0.47 | -5.77 | -1,227.66 | -0.31 | -0.21 |
| Mar 2020 | 0.18 | -0.34 | -188.89 | -0.39 | -0.26 |
| Mar 2019 | 0.06 | -0.14 | -233.33 | -1.01 | -0.67 |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales growth | -60.0% | +200.0% | +161.1% | +10.6% | +17.3% | +11.5% | +14.7% | -3.8% |
| Operating profit growth | – | – | – | – | – | – | – | – |
| Net profit growth | – | – | – | – | – | – | – | – |
| EPS growth | – | – | – | – | – | – | – | – |
| OPM % | -233.3% | -188.9% | -1227.7% | -26.9% | -13.1% | -11.8% | 0.0% | 16.0% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
No AI analysis generated yet for Dolphin Medical Services.
Get Free AI Stock Analysis FREE →Dolphin Medical MD, CEO and two directors resign with immediate effect - scanx.trade
Dolphin Medical Services accepts Vaishnavi Sharma's resignation as CFO - scanx.trade
Dolphin Medical Services open offer date set for Jul 17, 2026 - scanx.trade
Dolphin Medical Services shares were last quoted at ₹6.31 (-4.8% on the day). Use the Refresh price button on this page for the latest available price. Prices are for information only.
Dolphin Medical Services has a price-to-earnings (P/E) ratio of 220.33 and a price-to-book (P/B) ratio of 0.78. The industry P/E is 101.02.
The 52-week high of Dolphin Medical Services is ₹9.57 and the 52-week low is ₹1.98.
The market capitalisation of Dolphin Medical Services is about ₹9.98 crore.
In the latest quarter (Jun 2026), Dolphin Medical Services reported sales of ₹0.21 crore (+23.5%) and net profit of ₹0.02 crore (-33.3%), compared with the same quarter last year.
This page is for information and is not investment advice. As per the data shown here, Dolphin Medical Services has a 3-year ROE of 0.00%, 3-year profit growth of 36.00%. Review the fundamentals, quarterly results and AI analysis on StockSpin, and consult a SEBI-registered adviser before investing.
Promoters hold about 26.44% of Dolphin Medical Services.
Dolphin Medical Services belongs to the Hospital & Healthcare Services sector.
All Hospital & Healthcare Services stocks · Browse all stocks A–Z